Risultati di ricerca
Özlem Türeci ( Siegen, 6 marzo 1967) è un medico e immunologa tedesca di origine turca. Lettrice all' Università di Magonza, Türeci è co-fondatrice, assieme al marito, Uğur Şahin, dell'azienda farmaceutica BioNTech, di cui dirige la divisione di ricerca medica.
Özlem Türeci (Turkish pronunciation: [ˈœzlem ˈtyredʒi]; born 6 March 1967) is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19.
Özlem Türeci is a physician and basic researcher in the field of immunology. She researches target structures with a view to developing new treatments for cancer, infectious diseases and diseases of the immune and nervous systems.
Özlem Türeci ist eine deutsche Medizinerin, Wissenschaftlerin und Unternehmerin. Seit 2021 ist sie Professorin für personalisierte Immuntherapie am Helmholtz-Institut für Translationale Onkologie und der Johannes Gutenberg-Universität Mainz. Türeci und ihr Ehemann Uğur Şahin waren 2008 Gründer von BioNTech, einem Unternehmen ...
TÜRECI LAB Lab focus. We aim at identifying new tumor biomarkers for early cancer detection and a personalized treatment approach using patient-derived immune cells. Therefore, a close collaboration between basic research and clinical science is foreseen.
Özlem Türeci is the cofounder and chief medical officer of BioNTech. She leads the clinical development of "Project Lightspeed," the company's successful effort to develop and distribute an mRNA-based vaccine against COVID-19, a historic achievement completed in less than one year.
16 dic 2020 · As creators of the first vaccine to win approval by two of the world’s most credible regulators, however, the FT’s award has gone to Dr Sahin and Dr Tureci. They are the symbol of a...
